BRITTANY WILLIAMS: Open Payments
NPI 1174211783 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,395 in 144 payments from 19 companies in 2025. Trend: 2023 $83 · 2024 $1,452 · 2025 $2,395
Food & beverage: $2,395
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 63 | $895 |
| Biogen, Inc. | 17 | $341 |
| Novartis Pharmaceuticals Corporation | 9 | $190 |
| ARGENX US, INC. | 6 | $149 |
| PFIZER INC. | 15 | $142 |
| Neurocrine BioSciences, Inc. | 7 | $116 |
| Lundbeck LLC | 5 | $110 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $104 |
| UCB, Inc. | 4 | $82 |
| Lilly USA, LLC | 3 | $68 |
Products named: QULIPTA, UBRELVY, TYSABRI, KESIMPTA, VYVGART HYTRULO, NURTEC ODT, INGREZZA, HYQVIA.
Industry payments across KY — which companies pay providers there.
